« Singapore to Pour $1B into Focused Biomedical R&D | Main | Novartis Takes $590 M Direct Hit to Pipeline - Down goes Zalbin »

10/04/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f4d78b49970b

Listed below are links to weblogs that reference EMA to Issue Guidelines for Biosimilar mAbs in November:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More on this from the Patent doc blog which also reminds us that the FDA will be holding hearings on the US biosimilar pathway to be developed on Nov 2nd and 3rd.
http://www.patentdocs.org/2010/10/guidelines-for-biosimilar-antibodies-in-europe-due-in-november.html

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada